MSL Trademark

Trademark Overview

On Friday, January 4, 2008, a trademark application was filed for MSL with the United States Patent and Trademark Office. The USPTO has given the MSL trademark a serial number of 77364544. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 12, 2020. This trademark is owned by Bach Pharma, Inc.. The MSL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations of monosodium luminol for treatment of metabolic distress, inflammatory conditions, infectious conditions, neurological disorders, proliferation diseases, cellular senescence, protein conformational diseases and use as an iron chelator and a proteostasis regulator
msl

General Information

Serial Number77364544
Word MarkMSL
Filing DateFriday, January 4, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 12, 2020
Registration Number3709404
Registration DateTuesday, November 10, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 9, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations of monosodium luminol for treatment of metabolic distress, inflammatory conditions, infectious conditions, neurological disorders, proliferation diseases, cellular senescence, protein conformational diseases and use as an iron chelator and a proteostasis regulator

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 12, 2020
Primary Code005
First Use Anywhere DateTuesday, January 31, 2006
First Use In Commerce DateTuesday, January 31, 2006

Trademark Owner History

Party NameBach Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Andover, MA 01845
Party NameBach Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Andover, MA 01845
Party NameBach Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Andover, MA 01845

Trademark Events

Event DateEvent Description
Friday, June 12, 2020CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, November 10, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, February 25, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, February 25, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 25, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 18, 2015TEAS SECTION 8 & 15 RECEIVED
Thursday, December 17, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 17, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 14, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, November 10, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, October 6, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, October 6, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 15, 2009STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 20, 2009USE AMENDMENT FILED
Tuesday, September 15, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 20, 2009TEAS STATEMENT OF USE RECEIVED
Tuesday, March 3, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 9, 2008PUBLISHED FOR OPPOSITION
Wednesday, November 19, 2008NOTICE OF PUBLICATION
Monday, November 3, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 31, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 31, 2008AMENDMENT FROM APPLICANT ENTERED
Friday, October 31, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 23, 2008ASSIGNED TO LIE
Wednesday, October 8, 2008PAPER RECEIVED
Friday, April 4, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 4, 2008NON-FINAL ACTION E-MAILED
Friday, April 4, 2008NON-FINAL ACTION WRITTEN
Thursday, April 3, 2008ASSIGNED TO EXAMINER
Tuesday, January 8, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

conditions diseases senescence cellular protein conformational regulator proteostasis chelator iron